ClearPoint Neuro, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
ClearPoint Neuro, Inc. (CLPT) reported Cash and Cash Equivalents, Period Increase (Decrease) of $11.28 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-13.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-13
- ClearPoint Neuro, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was $11.28M.
- ClearPoint Neuro, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was -$539.45K.
- ClearPoint Neuro, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$1.23M.
- ClearPoint Neuro, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $4.97M.
- ClearPoint Neuro, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $2.59M.
- ClearPoint Neuro, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$6.19M, a 203.59% decline from fiscal 2017.
- ClearPoint Neuro, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $5.97M.
- ClearPoint Neuro, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$2.09M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2020-03-31 | $11.28M 10-Q · filed 2020-05-13 | $10.74M derived: sum of 2 quarters · filed 2020-05-13 | $9.51M derived: sum of 3 quarters · filed 2020-05-13 | $14.48M derived: sum of 4 quarters · filed 2020-05-13 |
| 2019-12-31 | -$539.45K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$1.77M derived: sum of 2 quarters · filed 2020-03-27 | $3.20M derived: sum of 3 quarters · filed 2020-03-27 | $2.59M 10-K · filed 2020-03-27 |
| 2019-09-30 | -$1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $3.74M derived: sum of 2 quarters · filed 2019-11-13 | $3.13M 10-Q · filed 2019-11-13 | $2.52M derived: sum of 4 quarters · filed 2020-05-13 |
| 2019-06-30 | $4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $4.36M 10-Q · filed 2019-08-12 | $3.75M derived: sum of 3 quarters · filed 2020-05-13 | $764.28K derived: sum of 4 quarters · filed 2020-05-13 |
| 2019-03-31 | -$609.46K 10-Q · filed 2020-05-13 | -$1.22M derived: sum of 2 quarters · filed 2020-05-13 | -$4.21M derived: sum of 3 quarters · filed 2020-05-13 | -$5.02M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | -$609.81K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$3.60M derived: sum of 2 quarters · filed 2020-03-27 | -$4.41M derived: sum of 3 quarters · filed 2020-03-27 | -$6.19M 10-K · filed 2020-03-27 |
| 2018-09-30 | -$2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$3.80M derived: sum of 2 quarters · filed 2019-11-13 | -$5.58M 10-Q · filed 2019-11-13 | -$7.32M derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | -$816.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$2.59M 10-Q · filed 2019-08-12 | -$4.33M derived: sum of 3 quarters · filed 2019-08-12 | -$6.04M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | -$1.78M 10-Q · filed 2019-05-13 | -$3.52M derived: sum of 2 quarters · filed 2019-05-13 | -$5.23M derived: sum of 3 quarters · filed 2019-05-13 | $5.54M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$3.45M derived: sum of 2 quarters · filed 2019-04-01 | $7.32M derived: sum of 3 quarters · filed 2019-04-01 | $5.97M 10-K · filed 2019-04-01 |
| 2017-09-30 | -$1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $9.06M derived: sum of 2 quarters · filed 2018-11-13 | $7.71M 10-Q · filed 2018-11-13 | $6.60M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $10.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $9.42M 10-Q · filed 2018-08-14 | $8.31M derived: sum of 3 quarters · filed 2018-08-14 | $10.72M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | -$1.35M 10-Q · filed 2018-05-15 | -$2.46M derived: sum of 2 quarters · filed 2018-05-15 | -$46.38K derived: sum of 3 quarters · filed 2018-05-15 | -$1.61M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $1.30M derived: sum of 2 quarters · filed 2018-03-21 | -$266.45K derived: sum of 3 quarters · filed 2018-03-21 | -$2.09M 10-K · filed 2018-03-21 |
| 2016-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $850.19K derived: sum of 2 quarters · filed 2017-11-06 | -$976.10K 10-Q · filed 2017-11-06 | $2.58M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$3.39M 10-Q · filed 2017-08-11 | $164.12K derived: sum of 3 quarters · filed 2017-08-11 | -$1.50M derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | -$1.83M 10-Q · filed 2017-05-09 | $1.73M derived: sum of 2 quarters · filed 2017-05-09 | $62.49K derived: sum of 3 quarters · filed 2017-05-09 | -$2.86M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $1.89M derived: sum of 2 quarters · filed 2017-03-09 | -$1.03M derived: sum of 3 quarters · filed 2017-03-09 | -$3.84M 10-K · filed 2017-03-09 |
| 2015-09-30 | -$1.67M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | -$4.59M derived: sum of 2 quarters · filed 2016-11-09 | -$7.39M 10-Q · filed 2016-11-09 | -$42.82K derived: sum of 4 quarters · filed 2016-11-09 |
| 2015-06-30 | -$2.92M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2016-09-21 | -$5.72M 10-Q/A · filed 2016-09-21 | $1.63M derived: sum of 3 quarters · filed 2016-09-21 | -$556.34K derived: sum of 4 quarters · filed 2016-09-21 |
| 2015-03-31 | -$2.81M 10-Q · filed 2016-05-06 | $4.54M derived: sum of 2 quarters · filed 2016-05-06 | $2.36M derived: sum of 3 quarters · filed 2016-05-06 | $637.28K derived: sum of 4 quarters · filed 2016-05-06 |
| 2014-12-31 | $7.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $5.17M derived: sum of 2 quarters · filed 2016-03-25 | $3.44M derived: sum of 3 quarters · filed 2016-03-25 | $5.73M 10-K · filed 2016-03-25 |
| 2014-09-30 | -$2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$3.91M derived: sum of 2 quarters · filed 2015-11-13 | -$1.62M 10-Q · filed 2015-11-13 | -$3.14M derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $559.84K 10-Q · filed 2015-08-10 | -$955.12K derived: sum of 3 quarters · filed 2015-08-10 | -$2.90M derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | $2.28M 10-Q · filed 2015-05-07 | $769.85K derived: sum of 2 quarters · filed 2015-05-07 | -$1.18M derived: sum of 3 quarters · filed 2015-05-07 | -$3.40M derived: sum of 4 quarters · filed 2015-05-07 |
| 2013-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | -$3.46M derived: sum of 2 quarters · filed 2015-03-17 | -$5.68M derived: sum of 3 quarters · filed 2015-03-17 | $1.90M 10-K · filed 2015-03-17 |
| 2013-09-30 | -$1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$4.17M derived: sum of 2 quarters · filed 2014-11-14 | $3.41M 10-Q · filed 2014-11-14 | $1.24M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | -$2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $5.36M 10-Q · filed 2014-08-11 | $3.19M derived: sum of 3 quarters · filed 2014-08-11 | $5.75M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | $7.58M 10-Q · filed 2014-05-13 | $5.41M derived: sum of 2 quarters · filed 2014-05-13 | $7.98M derived: sum of 3 quarters · filed 2014-05-13 | $7.52M derived: sum of 4 quarters · filed 2014-05-13 |
| 2012-12-31 | -$2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $397.05K derived: sum of 2 quarters · filed 2014-03-28 | -$61.88K derived: sum of 3 quarters · filed 2014-03-28 | $1.47M 10-K · filed 2014-03-28 |
| 2012-09-30 | $2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $2.11M derived: sum of 2 quarters · filed 2013-11-13 | $3.64M 10-Q · filed 2013-11-13 | $3.72M derived: sum of 4 quarters · filed 2013-11-13 |
| 2012-06-30 | -$458.93K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-14 | $1.08M 10-Q · filed 2013-08-14 | $1.15M derived: sum of 3 quarters · filed 2013-08-19 | $625.66K derived: sum of 4 quarters · filed 2013-08-19 |
| 2012-03-31 | $1.54M 10-Q/A · filed 2013-08-19 | $1.61M derived: sum of 2 quarters · filed 2013-08-19 | $1.08M derived: sum of 3 quarters · filed 2013-08-19 | $1.67M derived: sum of 4 quarters · filed 2013-08-19 |
| 2011-12-31 | $75.38K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-19 | -$451.82K derived: sum of 2 quarters · filed 2013-08-19 | $136.62K derived: sum of 3 quarters · filed 2013-08-19 | -$1.43M 10-K/A · filed 2013-08-19 |
| 2011-09-30 | -$527.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $61.23K derived: sum of 2 quarters · filed 2012-11-14 | -$1.51M 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $588.43K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-08-14 | -$980.02K 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | -$1.57M 10-Q/A · filed 2012-06-07 | |||
| 2010-12-31 | -$991.82K 10-K/A · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |